Substituted fused imidazoles and pyrazoles and use thereof

US9023849B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Markus Follmann
• Johannes-Peter Stasch · Wuppertal, DE
• Gorden Redlich · Bochum, DE
• Nils Griebenow · Milford, US
• Dieter Lang · Velbert, DE
• Frank Wunder · Wuppertal, DE
• Holger Paulsen · Wuppertal, DE
• Walter Hubsch · Wuppertal, DE
• Alexandros Vakalopoulos · Hilden, DE
• Adrian Tersteegen · Wuppertal, DE

Key dates

• Filing date: Jan 8, 2013
• Grant date: May 5, 2015
• Expiry date: Jan 8, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D519/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel substituted fused imidazoles and pyrazoles, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases and to the use thereof producing medicaments for the treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of cardiovascular disorders.